P
Pallavi Bhargava
Researcher at Henry Ford Health System
Publications - 14
Citations - 1229
Pallavi Bhargava is an academic researcher from Henry Ford Health System. The author has contributed to research in topics: Methylprednisolone & Hazard ratio. The author has an hindex of 6, co-authored 13 publications receiving 923 citations. Previous affiliations of Pallavi Bhargava include Henry Ford Hospital.
Papers
More filters
Journal ArticleDOI
Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19.
Samia Arshad,Paul E. Kilgore,Zohra S Chaudhry,Gordon Jacobsen,Dee Dee Wang,Kylie Huitsing,Indira Brar,George Alangaden,George Alangaden,Mayur Ramesh,John E. McKinnon,William W. O'Neill,Marcus J. Zervos,Marcus J. Zervos,Varidhi Nauriyal,Asif Abdul Hamed,Owais Nadeem,Jennifer Swiderek,Amanda Godfrey,Jeffrey H. Jennings,Jayna Gardner-Gray,Adam M. Ackerman,Jonathan Lezotte,Joseph Ruhala,Raef Fadel,Amit Vahia,Smitha Gudipati,Tommy Parraga,Anita Shallal,Gina Maki,Zain Tariq,Geehan Suleyman,Nicholas Yared,Erica Herc,Johnathan Williams,Odaliz Abreu Lanfranco,Pallavi Bhargava,Katherine Reyes +37 more
TL;DR: The role of hydroxychloroquine therapy alone and in combination with azithromycin in hospitalized patients positive for COVID-19 was evaluated, and the primary outcome was in-hospital mortality.
Journal ArticleDOI
Early Short-Course Corticosteroids in Hospitalized Patients With COVID-19.
Raef Fadel,Austin R Morrison,Amit Vahia,Zachary R Smith,Zohra S Chaudhry,Pallavi Bhargava,Joseph Miller,Rachel M. Kenney,George J Alangaden,Mayur Ramesh +9 more
TL;DR: An early short course of methylprednisolone in patients with moderate to severe COVID-19 reduced escalation of care and improved clinical outcomes.
Journal ArticleDOI
Acute Pulmonary Embolism and COVID-19.
Neo Poyiadji,Peter Cormier,Parth Y Patel,Mohamad Omar Hadied,Pallavi Bhargava,Kanika Khanna,Jeffrey Nadig,Thomas Keimig,David L. Spizarny,Nicholas Reeser,Chad L Klochko,Edward L. Peterson,Thomas Song +12 more
TL;DR: Risk factors for pulmonary embolism in patients with coronavirus disease 2019 include obesity, an elevated d-dimer value, elevated C-reactive protein level, and a rising d-Dimer value over time.
Journal ArticleDOI
Cardiac Tamponade Secondary to COVID-19.
Mohammed Dabbagh,Lindsey Aurora,Penny L D'Souza,Allison Weinmann,Pallavi Bhargava,Mir B Basir +5 more
TL;DR: A 67-year-old female presented with upper respiratory symptoms and was diagnosed with COVID-19 and found to have a large hemorrhagic pericardial effusion with echocardiographic signs of tamponade and mild left ventricular impairment.
Posted ContentDOI
Early Short Course Corticosteroids in Hospitalized Patients with COVID-19
Raef Fadel,Austin R Morrison,Amit Vahia,Zachary R Smith,Zohra S Chaudhry,Pallavi Bhargava,Joseph Miller,Rachel M. Kenney,George J Alangaden,Mayur Ramesh +9 more
TL;DR: An early short course of methylprednisolone in patients with moderate to severe COVID-19 reduced escalation of care and improved clinical outcomes.